The next three to five years will require the continent to ensure there is sustainable business beyond Covid-19.
The World Health Organisation has enlisted a team of South African researchers to produce a new mRNA Covid-19 vaccine, but with no recipe to follow, it’s not an easy task
Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it